Education

Medical School
Peking University Health Science Center, China (1992)
Graduate School
Kyoto University, Japan (2001), Pharmacology
Postdoctoral Fellowship
UCLA/Howard Hughes Medical Institute (2005), Pathology/lab Medicine
Internship
UC San Diego Health (2006), Pathology
Residency
Loma Linda University Medical Center (2009), Pathology
Fellowship
City of Hope National Medical Center (2010), Hematopathology

Research Interest

  • Molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD
  • Sickle cell disease, thrombosis, and vascular biology
  • Viral infections and cancergenesis, and cancer stem cells

Publications

Featured Publications LegendFeatured Publications

FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression.
Zhang J, Kong X, Zhang Y, Sun W, Wang J, Chen M, Chen X, J. Pathol. 2020 Apr
Mutant p53 antagonizes p63/p73-mediated tumor suppression via Notch1.
Zhang J, Sun W, Kong X, Zhang Y, Yang HJ, Ren C, Jiang Y, Chen M, Chen X, Proc. Natl. Acad. Sci. U.S.A. 2019 Nov
Philadelphia chromosome-negative acute leukemia in chronic myeloid leukemia.
Gong Z, Xu ML, Chen M, Cui W, Kantarjian HM, Cortes JE, Zhou T, Tang G, Wang W, Medeiros LJ, Hu S, Am. J. Hematol. 2019 Jul
Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.
Zhang Y, Feng X, Zhang J, Chen M, Huang E, Chen X, Oncogene 2019 Jul

Books

Featured Books Legend Featured Books